PDS Biotechnology secures up to $22.55M PIPE financing
PDS Biotechnology Corp. secured a Nant Capital-led PIPE totaling up to $22.55M, with an initial close of about $11.55M and an $11M milestone tied to FDA Phase 3 protocol filing.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.